A GLS cutoff of >-19.9% was a strong independent predictor of long-term left ventricular dysfunction and may become an appropriate indication for intervention in the setting of normal EF.
Moreover, tubular dysfunction may only become evident after years of TDF therapy, even in those who have normal kidney function at the time of starting TDF; this emphasizes the importance of continued monitoring in all patients treated with TDF.
If effective tissue perfusion is persistently impaired and not corrected, the cellular dysfunction and organ failure may become irreversible.
Infections are often associated with severe blood-CSF barrier dysfunction; the presence of OCB may become undetectable in those cases because of a relative increase of the blood-derived polyclonal IgG fraction.
When stimulation of D3 activity is compounded by other factors involved in pathologic remodeling, e.g., TGF-β signaling, the decrease in cellular T3 levels may further impact on the expression of T3-dependent genes that are implicated in the development of contractile dysfunction, and the adaptive response may become part of the problem.
If future investigations confirm the Nav1.7 sodium channels dysfunction in FM; then sodium channel blockers may become a therapeutic option.
As the eyes are literally the window to the brain, researchers have long recognized the potential that eye movements may provide early clues to neurologic dysfunction before other more serious signs of brain injury may become apparent.
When energy metabolic dysfunction occurs, the living cell microenvironment and surroundings encounter alterations, which may become conducive to cancer cell proliferation.
BT may not just be a drink anymore, it may become a drug to treat hypertension and hypertension-associated endothelial dysfunction.
Similarly, exposure to environmental chemicals during development can cause abnormal gene regulation (e.g., via epigenetic mechanisms) which may persist and may become apparent later in life as increased risk of dysfunctions or diseases.
